Valentis Pockets $14M in Public Offering | GenomeWeb

Valentis Pockets $14M in Public Offering

Dec 27, 2001

NEW YORK, Dec. 27 - Valentis has pocketed $13.8 million in an underwritten public offering of its common stock, the company said on Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Oct 12, 2015

Cancer Genetics Completes $14M Purchase of Response Genetics' Assets

Nov 17, 2015

Diatherix, Color Genomics Receive CAP Accreditation

Sep 27, 2016

Color Genomics Raises $45M in Series B Financing; Offers Patient Families Discounted Testing

Apr 11, 2016

Color Genomics Makes Low-Cost Breast and Ovarian Cancer Genetic Risk Test Available Abroad

Premium

Feb 18, 2016

NIH Commits $14M to Fund Biomedical Informatics, Data Science Training Programs

Jul 26, 2016

CellMax Life Launches With $14M in Funding, Early Colorectal Cancer Detection Test